Project
Amgen 20200234
Aborted - recruitment paused ยท 2021 until 2023
Rubbert-Roth Andrea, Peischl Riana
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Aborted - recruitment paused
Start Date
2021
End Date
2023
Financing
Others
Brief description/objective
A Phase 2b Dose Ranging Study to Evaluate the Efficacy and Safety of Efavaleukin Alfa in Subjects with Active Systemic Lupus Erythematosus With Inadequate Response to Standard of Care Therapy.